Literature DB >> 7550331

A common BRCA1 mutation in the Ashkenazim.

D E Goldgar, P R Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550331     DOI: 10.1038/ng1095-113

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  6 in total

Review 1.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer.

Authors:  Q Gao; S Neuhausen; S Cummings; M Luce; O I Olopade
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

Authors:  Pedro Kringen; Yun Wang; Vanessa Dumeaux; Jahn M Nesland; Gunnar Kristensen; Anne-Lise Borresen-Dale; Anne Dorum
Journal:  BMC Cancer       Date:  2005-10-17       Impact factor: 4.430

4.  Ethnic differences in cancer incidence: a marker for inherited susceptibility?

Authors:  F D Gilliland
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

5.  Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan.

Authors:  M Takano; H Aida; I Tsuneki; K Takakuwa; I Hasegawa; H Tanaka; M Saito; S Tsuji; T Sonoda; M Hatae; J T Chen; K Takahashi; K Hasegawa; N Toyoda; N Saito; M Yakushiji; T Araki; K Tanaka
Journal:  Jpn J Cancer Res       Date:  1997-04

6.  Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients.

Authors:  G Kijima; Y Murakami; N Ohuchi; S Satomi; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1998-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.